跳至主要内容
临床试验/ISRCTN11041050
ISRCTN11041050进行中(未招募)未知

Sarscov2 Immunity & REinfection EvaluatioN: Impact of detectable anti-SARS-COV2 on the subsequent incidence of COVID-19 in healthcare workers

Public Health England0 个研究点目标入组 35,768 人开始时间: 2021年1月12日最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
35,768

研究概览

简要总结

2020 Preprint results in https://doi.org/10.1101/2020.12.15.20247981 protocol (not peer reviewed) in preprint (added 08/01/2021) 2021 Preprint results in http://dx.doi.org/10.2139/ssrn.3790399 non-peer-reviewed results on efficacy of BNT162b2 mRNA vaccine in preprint (added 16/03/2021) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35172051/ Protection from reinfection by previous infection or vaccination (added 17/02/2022) 2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/35768083/ (added 30/06/2022) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35858689/ results on incidence of, risk factors for, and impact of vaccines on primary SARS-CoV-2 infection during the second wave in England (added 21/07/2022) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36089104/ Nest case-control study investigating antibody correlates of protection (added 12/09/2022)

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • Hospital healthcare worker willing to consent for regular follow up for 12 months with swabs and blood samples

排除标准

  • Unwilling to participate in regular follow up

研究者

相似试验